Don’t Write Actemra Off Yet: Roche Drug Found To Be Lifesaving In COVID-19

Shown To Cut Deaths By 8%

After failing in five earlier trials, Actemra shows significant life-saving benefits for patients with severe COVID-19.

ICU
Actemra produced an 8% improvement in COVID-19 patients' chance of survival compared to standard care.

More from Business

More from Scrip